Penumbra
PEN
#2098
Rank
NZ$12.24 B
Marketcap
$315.19
Share price
-2.90%
Change (1 day)
-25.32%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - P/B ratio

P/B ratio as of September 2024 : 6.65

According to Penumbra's latest financial reports the company has a price-to-book ratio of 6.65.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Penumbra - P/B ratio (from 2015 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-318.23-2.64%
2022-12-318.46-24.83%
2021-12-3111.312.94%
2020-12-319.96-15.85%
2019-12-3111.818.85%
2018-12-319.9624.91%
2017-12-317.985.3%
2016-12-317.579.47%
2015-12-316.92
2014-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio differencediff. Country
5.92-10.93%๐Ÿ‡บ๐Ÿ‡ธ USA
4.51-32.27%๐Ÿ‡บ๐Ÿ‡ธ USA